CTNNB1 and hepatocellular carcinoma: An HCC subtype characterized by TP53 mutation, high fractional allelic loss, significant global hypomethylation, and absence of CTNNB1 mutation were noted to predict shorter recurrence-free survival in patients who underwent liver transplantation [70].